← Eichor
Study identifier: NCT05490238 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

DIStal Versus COnventional Radial Access for COMPLEX Large-bore Percutaneous Coronary Intervention

Condition: Vascular Access Site Occlusion  ·  Sponsor: IGLESIAS Juan Fernando

PhaseNA
Planned participants708
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The use of the distal radial artery has recently emerged as a promising alternative access route to further reduce the risk of radial artery occlusion (RAO) and has been endorsed by recent International Consensus documents. The feasibility of a distal radial access (DRA) for coronary angiography and/or PCI has been demonstrated in several observational clinical registries and small-sized randomized clinical trials. In the recent prospective, multicenter, open label, randomized, controlled DIStal vs Conventional RADIAL access (DISCO RADIAL) trial, DRA was associated with low and similar rates of RAO at discharge when compared to conventional TRA among patients undergoing coronary angiography and/or PCI. There is however limited evidence on the feasibility and safety of 7F DRA for PCI. In a prospective, multicenter, observational study including 41 patients undergoing CTO PCI using a left DRA with a 7F GLIDESHEATH SLENDER® (Terumo Corp., Tokyo, Japan), technical success was achieved in 90.3% of patients and procedural success was achieved in 78.1% of patients. No post-procedural DRA RAO were detected by clinical assessment and Doppler ultrasound examination, and no radial artery occlusions at the site of the forearm were found. Doppler ultrasound imaging of the DRA at one month was available in 67.6% of patients, with only one case (4.3%) of DRA RAO. This proof-of-concept study demonstrates that DRA using a 7F GLIDESHEATH SLENDER® (Terumo Corp., Tokyo, Japan) for CTO PCI is fe…

This description comes directly from the study's public registry record.

Talk to the study team

Véronique Menoni  ·  +41795530516  ·  veronique.menoni@hug.ch

Always discuss trial participation with your own doctor first.

Locations (9)

Clinique St. Joseph Arlon - Groupe VivaliaArlon, BelgiumRecruiting
CHU Saint-PierreBrussels, BelgiumRecruiting
CHU de CharleroiCharleroi, BelgiumRecruiting
Hôpital de La Louvière - Site JolimontLa Louvière, BelgiumRecruiting
Agaplesion Bethesda Krankenhaus BergedorfHamburg, GermanyRecruiting
Patras University HospitalPátrai, GreeceRecruiting
Humanitas Research HospitalMilan, ItalyRecruiting
Basel University HospitalBasel, Basel, SwitzerlandRecruiting
Geneva University HospitalsGeneva, Canton of Geneva, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05490238